Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 27, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Reni Benjamin Reiterated (STRO) at Buy and Held Target at $17 on, Jun 27th, 2023
Reni Benjamin of JMP Securities, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $17 on, Jun 27th, 2023.
Reni has made no other calls on STRO in the last 4 months.
There are 2 other peers that have a rating on STRO. Out of the 2 peers that are also analyzing STRO, 0 agree with Reni's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Reni
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $16 on, Tuesday, May 16th, 2023
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $20 on, Friday, March 31st, 2023
